Multiplexed electronic counting of scarce protein targets using nucleic acid nanoparticles

使用核酸纳米粒子对稀有蛋白质靶标进行多重电子计数

基本信息

  • 批准号:
    10353490
  • 负责人:
  • 金额:
    $ 24.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-05-01 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY This interdisciplinary project synergizes the expertise of three research groups for a proof-of-principle demonstration of a novel approach for accurate and sensitive detection of scarce protein biomarkers. The key innovative element of the approach is the use of wireframe-like nucleic acid nanoparticles (NANPs) to bind protein targets with high affinity either directly or by means of auxiliary antibody proteins. Binding of the protein targets is detected by first incubating the sample with a cocktail of NANPs and then examining them using a nanopore in a solid-state membrane. Protein detection relies on measurement of the ionic current flowing through the nanopore: the ionic current and particle dwell time decreases by a characteristic amount when a NANP of a certain type enters the nanopore. Importantly, by matching the physical dimensions of the NANP to the physical dimension of the nanopore, we expect to dramatically increase the residence type of the nucleic acid nanoparticles within the nanopore and thereby achieve ultra-sensitive (sub-picomolar range) detection of the protein-bound biomarkers. By designing our NANP probes to produce distinct ionic signatures when bound to their protein targets, we will achieve multiplex detection of several protein species using the same nanopore as well as combinatorial detection of biomarkers by assembling the NANP probes and protein biomarkers into a sandwich like structures. The project will be carried out by the Afonin group at UNC Charlotte that will design NANPs, the Wanunu group at Northeastern University that will perform the nanopore detection experiments, and the Aksimentiev group that will use an arsenal of modeling techniques to optimize and improve the detection strategy. Our ultra-sensitive, portable, rapid, and potentially low-cost technology for quantification of protein levels is expected to find broad use for the analysis of biological samples, eventually offering sensitive, reliable, and minimally invasive identification of disease-indicative biomarkers that could be important innovations for early-stage diagnostics of cancer and other diseases.
项目总结 这个跨学科的项目结合了三个研究小组的专业知识,以进行原则证明 展示了一种准确而灵敏地检测稀缺蛋白质生物标志物的新方法。钥匙 该方法的创新元素是使用线框状核酸纳米颗粒(NANP)结合 直接或通过辅助抗体蛋白具有高亲和力的蛋白质靶标。蛋白质的结合 检测目标的方法是首先将样本与NANP的鸡尾酒孵化,然后使用 固态膜中的纳米孔。蛋白质的检测依赖于流经的离子电流的测量 纳米孔:当NANP的NANP为 某些类型进入纳米孔。重要的是,通过将NANP的物理尺寸与物理 纳米孔的尺寸,我们预计将显著增加核酸的驻留类型 纳米孔内的纳米颗粒,从而实现超灵敏(亚皮摩尔范围)对 蛋白质结合的生物标记物。通过将我们的NANP探针设计为在结合到 他们的蛋白质靶标,我们将使用相同的纳米孔实现对几种蛋白质物种的多重检测 以及通过将NANP探针和蛋白质生物标记组装成 三明治状的结构。该项目将由北卡罗来纳大学夏洛特分校的阿弗宁小组实施,该小组将设计 东北大学的Wanunu小组将进行纳米孔探测实验,以及 Aksimentiev小组将使用大量建模技术来优化和改进检测 策略。我们的超灵敏、便携、快速、潜在低成本的蛋白质定量技术 预计Level将广泛用于生物样本的分析,最终提供灵敏、可靠、 以及微创识别疾病指示生物标记物,这可能是 癌症和其他疾病的早期诊断。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kirill A Afonin其他文献

Kirill A Afonin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kirill A Afonin', 18)}}的其他基金

Multiplexed electronic counting of scarce protein targets using nucleic acid nanoparticles
使用核酸纳米粒子对稀有蛋白质靶标进行多重电子计数
  • 批准号:
    10611370
  • 财政年份:
    2022
  • 资助金额:
    $ 24.33万
  • 项目类别:
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
SMART NANP:与人体免疫系统通讯和调节治疗反应的新分子平台
  • 批准号:
    10331771
  • 财政年份:
    2021
  • 资助金额:
    $ 24.33万
  • 项目类别:
SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
SMART NANP:与人体免疫系统通讯和调节治疗反应的新分子平台
  • 批准号:
    10557793
  • 财政年份:
    2021
  • 资助金额:
    $ 24.33万
  • 项目类别:
Administrative Supplement to SMART NANPs: new molecular platform for communication with human immune system and modulation of therapeutic responses
SMART NANP 的行政补充:用于与人体免疫系统沟通和调节治疗反应的新分子平台
  • 批准号:
    10798083
  • 财政年份:
    2021
  • 资助金额:
    $ 24.33万
  • 项目类别:
Characterization of various multifunctional nucleic acid nanoparticles and understanding their immunotoxicity
各种多功能核酸纳米粒子的表征并了解其免疫毒性
  • 批准号:
    10013239
  • 财政年份:
    2017
  • 资助金额:
    $ 24.33万
  • 项目类别:
Characterization of various multifunctional nucleic acid nanoparticles and understanding their immunotoxicity
各种多功能核酸纳米粒子的表征并了解其免疫毒性
  • 批准号:
    9384048
  • 财政年份:
    2017
  • 资助金额:
    $ 24.33万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 24.33万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 24.33万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 24.33万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 24.33万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 24.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 24.33万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 24.33万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 24.33万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 24.33万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 24.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了